GSC
IART icon

Ground Swell Capital’s Integra LifeSciences IART Stock Holding History

Ground Swell Capital’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$10K Buy
489
+308
+170% +$6.13K 0.02% 957
2014
Q2 		$3K Buy
+181
New +$3.37K 0.01% 1306

Other funds holding IART

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ground Swell Capital's IART Position: Q3 2014 in Review

Ground Swell Capital increased its Integra LifeSciences (IART) stake by 170% in Q3 2014, buying an estimated $6.13K and bringing the position to 489 shares worth $10K. The position accounts for 0.02% of the portfolio, ranked #957.

Ground Swell Capital first reported a position in IART in Q2 2014 and has held it in 2 quarters since. 143 funds tracked by Wall St. Rank hold IART as of Q3 2014.

  • Ground Swell Capital held 489 shares of Integra LifeSciences worth $10K as of Q3 2014.
  • Ground Swell Capital bought 308 Integra LifeSciences shares in Q3 2014, an estimated $6.13K.
  • Integra LifeSciences made up 0.02% of Ground Swell Capital's portfolio in Q3 2014, its #957 holding.
  • Ground Swell Capital first reported a position in Integra LifeSciences in Q2 2014 and has held it in 2 quarters since.
  • 143 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.